Published in Thromb Res on October 01, 1980
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogs. J Clin Invest (1988) 1.14
Platelet inhibition with Ticlopidine in atherosclerotic intermittent claudication. J Clin Pathol (1982) 0.84
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature (1996) 8.02
Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med (1994) 6.05
Cerebral venous thrombosis--a review of 38 cases. Stroke (1985) 4.12
Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet (1997) 3.68
Increased fetal loss in women with heritable thrombophilia. Lancet (1996) 3.34
Isolated intracranial hypertension as the only sign of cerebral venous thrombosis. Neurology (1999) 3.12
Cerebral venous thrombosis. Neurol Clin (1992) 2.79
The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med (2001) 2.70
Headache as the only neurological sign of cerebral venous thrombosis: a series of 17 cases. J Neurol Neurosurg Psychiatry (2005) 2.54
Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography. Stroke (1982) 2.40
[Peripheral neuropathies caused by perhexiline maleate. Apropos of 7 cases]. Coeur Med Interne (1977) 2.30
"Crossed cerebellar diaschisis" in human supratentorial brain infarction. Trans Am Neurol Assoc (1981) 2.19
MR imaging features of isolated cortical vein thrombosis: diagnosis and follow-up. AJNR Am J Neuroradiol (2008) 2.19
Coupling between regional blood flow and oxygen utilization in the normal human brain. A study with positron tomography and oxygen 15. Arch Neurol (1983) 2.19
Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. J Thromb Haemost (2006) 2.17
Time course of symptoms in extracranial carotid artery dissections. A series of 80 patients. Stroke (1995) 2.13
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost (2005) 2.13
"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke (1983) 2.09
Case-control study of migraine and risk of ischaemic stroke in young women. BMJ (1995) 2.03
Headache following carotid endarterectomy: a prospective study. Cephalalgia (1992) 2.02
Cerebral venous thrombosis: nothing, heparin, or local thrombolysis? Stroke (1999) 2.01
Aspirin vs anticoagulation in carotid artery dissection: a study of 298 patients. Neurology (2009) 1.98
Antithrombotic therapy for venous thromboembolic disease. Chest (2001) 1.94
Long-term follow-up of aneurysms developed during extracranial internal carotid artery dissection. Neurology (1999) 1.82
The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med (1992) 1.80
Migraine and risk of ischaemic stroke: a case-control study. BMJ (1993) 1.79
A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p. Ann Neurol (1995) 1.74
Effects of thalamic stroke on energy metabolism of the cerebral cortex. A positron tomography study in man. Brain (1986) 1.70
Recommendations on biosimilar low-molecular-weight heparins. J Thromb Haemost (2009) 1.68
Intra-arterial thrombus visualized on T2* gradient echo imaging in acute ischemic stroke. Cerebrovasc Dis (2005) 1.67
Head pain in non-traumatic carotid artery dissection: a series of 65 patients. Cephalalgia (1994) 1.67
Antithrombotic therapy for venous thromboembolic disease. Chest (1998) 1.67
Autosomal dominant leukoencephalopathy and subcortical ischemic stroke. A clinicopathological study. Stroke (1993) 1.65
Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. BMJ (1991) 1.65
Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke (2000) 1.62
Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke (2003) 1.60
Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence. Int Angiol (2001) 1.59
Internal carotid artery dissection: an update. J Neurol Sci (1998) 1.57
Crossed cerebellar diaschisis. Further studies. Brain (1986) 1.56
Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis. Stroke (1996) 1.55
Carotid and vertebral artery dissections: three-dimensional time-of-flight MR angiography and MR imaging versus conventional angiography. Radiology (1994) 1.55
Tolerance of the human liver to prolonged normothermic ischemia. A biological study of 20 patients submitted to extensive hepatectomy. Arch Surg (1978) 1.55
Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) (1990) 1.55
Extracranial vertebral artery dissections: a review of 13 cases. Stroke (1988) 1.55
Long-term prognosis in cerebral venous thrombosis. Follow-up of 77 patients. Stroke (1996) 1.54
Gender differences in spontaneous cervical artery dissection. Neurology (2006) 1.52
Ophthalmologic manifestations of internal carotid artery dissection. Am J Ophthalmol (1998) 1.52
Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet (2001) 1.47
Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation (1997) 1.46
A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet (1993) 1.46
Regional cerebral blood flow and oxygen consumption in human aging. Stroke (1984) 1.46
Cerebral venous thrombosis in systemic lupus erythematosus. Stroke (1990) 1.45
Problems of oral anticoagulation in an adult with homozygous protein C deficiency and late onset of thrombosis. Thromb Haemost (1993) 1.44
Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost (2004) 1.44
Patterns of MRI lesions in CADASIL. Neurology (1998) 1.43
A European view on the North American fifth consensus on antithrombotic therapy. Chest (2000) 1.43
Patent foramen ovale: is stroke due to paradoxical embolism? Stroke (1993) 1.42
Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke (1999) 1.41
Effectiveness of oral diclofenac in the acute treatment of common migraine attacks: a double-blind study versus placebo. Cephalalgia (1991) 1.40
[CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)]. J Mal Vasc (1996) 1.40
Cerebral venous thrombosis in Behçet's disease: clinical study and long-term follow-up of 25 cases. Neurology (1992) 1.40
Fate of the patient with chronic leg ischaemia. A review article. J Cardiovasc Surg (Torino) (1989) 1.39
[Anticoagulant clinics are they effective in France? Performance evaluation of six anticoagulant clinics concerning the management of vitamin K antagonists]. Rev Med Interne (2013) 1.39
[Recommendations for the use of intravenous thrombolytic therapy in cerebrovascular ischemic accident. French Society of Neurovascular Disorders]. Rev Neurol (Paris) (2000) 1.39
Cerebral infarction and familial protein S deficiency. Stroke (1990) 1.39
Rapid aequorin loading into platelets in the presence of DMSO--characteristics of the responses (changes in light transmission and in calcium) to various agonists. Thromb Haemost (1991) 1.38
De novo mutation in the Notch3 gene causing CADASIL. Ann Neurol (2000) 1.36
Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study. J Cereb Blood Flow Metab (1984) 1.35
Very small (border zone) cerebellar infarcts. Distribution, causes, mechanisms and clinical features. Brain (1993) 1.35
Cerebral hemodynamics in CADASIL before and after acetazolamide challenge assessed with MRI bolus tracking. Stroke (2000) 1.29
Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen. Thromb Haemost (1995) 1.28
Autosomal dominant syndrome with strokelike episodes and leukoencephalopathy. Stroke (1991) 1.28
Triple and quadruple spontaneous cervical artery dissection: presenting characteristics and long-term outcome. J Neurol Neurosurg Psychiatry (2008) 1.26
Migraine--a risk factor for dissection of cervical arteries. Headache (1989) 1.26
CT in cerebral thrombophlebitis. Neuroradiology (1985) 1.25
Use of monitoring software to improve the measurement of carotid wall thickness by B-mode imaging. J Hypertens Suppl (1992) 1.22
[Coagulation disorders after reinjection of concentrated ascitic fluid. Preliminary study]. Med Chir Dig (1973) 1.22
Small abnormal echos after mitral valve replacement with bileaflet mechanical prostheses: predisposing factors and effect on thromboembolism. J Heart Valve Dis (1993) 1.19
[Coagulation disorders during continuous reinjections of ascitic fluid. Fibrinolysis or intravascular coagulation?]. Nouv Presse Med (1973) 1.19
The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat. Thromb Haemost (1996) 1.17
Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations. Arterioscler Thromb Vasc Biol (1997) 1.17
Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med (1998) 1.17
Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin). Blood (1987) 1.16
Successful progressive anticoagulation in a severe protein C deficiency and previous skin necrosis at the initiation of oral anticoagulant treatment. Thromb Haemost (1984) 1.16
Beta fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoins sur l'Infarctus du Myocarde. Circulation (1996) 1.16
Changing pattern of headache pointing to cerebral venous thrombosis after lumbar puncture and intravenous high-dose corticosteroids. Headache (1999) 1.14
[Cervical artery dissection: recent data physiopathologic hypotheses]. Rev Med Interne (1999) 1.12
[Value of the platelet count using electronic counter]. Pathol Biol (Paris) (1970) 1.11
Migraine and the risk of cervical artery dissection: a case-control study. Neurology (2002) 1.11